Vimarsana
Biggest News Aggregation in the World

Page 2 - Single Dose Vials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Single Dose Vials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Single Dose Vials Today - Breaking & Trending Today

Glenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials - Vimarsana News

Glenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials

/PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce it has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL)...

Glenmark Pharmaceuticals launches Bumetanide Injection - Vimarsana News

Glenmark Pharmaceuticals launches Bumetanide Injection

Glenmark Pharmaceuticals Inc., USA has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials, the generic version of Bumex® Injection.

Alembic Pharma gets Final Approval for Glycopyrrolate Injection USP from its General Sterile Facility - Vimarsana News

Alembic Pharma gets Final Approval for Glycopyrrolate Injection USP from its General Sterile Facility

Alembic Pharmaceuticals Ltd today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application for Glycopyrrolate Injection.

Aurobindo Pharma's step-down subsidiary bags USFDA Approval for Pemetrexed for Injection; stock adds ~1% - Vimarsana News

Aurobindo Pharma's step-down subsidiary bags USFDA Approval for Pemetrexed for Injection; stock adds ~1%

This is the 139th ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.

Medications in Single-Dose Vials and Implications of Discarded Injectable Drugs: A National Academies Report | Clinical Pharmacy and Pharmacology | JAMA - Vimarsana News

Medications in Single-Dose Vials and Implications of Discarded Injectable Drugs: A National Academies Report | Clinical Pharmacy and Pharmacology | JAMA

1Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University in the City of New York 2Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington 3Healthcare Quality and Policy, Hutchinson Institute for Cancer Outcomes Research, Seattle, Washington 4Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine, Washington, DC JAMA. Published online February 25, 2021. doi:10.1001/jama.2021.2414